◀ Back to GH1

C9ORF3 — GH1

Text-mined interactions from Literome

Duval et al., Prog Neuropsychopharmacol Biol Psychiatry 2000 : However, there were no differences in adrenocorticotropic hormone ( ACTH ), cortisol, prolactin and growth hormone (GH) responses to APO between MDEPs and MDEs and HCs
Meltzer et al., Biol Psychiatry 2001 : This study primarily examined the cortisol, but also the prolactin (PRL) and growth hormone (GH) , response to APO in patients with SCH compared to normal controls, as well as the relationship between endocrine measures and response to antipsychotic drug treatment
Fahlke et al., Alcohol Clin Exp Res 2012 (Alcoholism) : The postsynaptic DRD2 function was measured by the growth hormone (GH) response to apomorphine (APO) and the postsynaptic a2-adrenoceptor function by GH response to clonidine ( CLON )
Balldin et al., Psychopharmacologia 1985 (Alcoholism...) : Dopamine ( DA ) sensitivity, assessed through maximal growth hormone (GH) response to stimulation by apomorphine (APO) ( 0.18-0.24 mg iv ) was studied in 16 chronic alcoholics newly admitted after a period of heavy alcohol intake
Brown et al., Psychiatry Res 1988 (Body Weight...) : The growth hormone (GH) response to apomorphine hydrochloride (APO) was examined monthly in 12 schizophrenic patients on drug holiday for up to 22 months and compared with age- and sex matched controls
Lal et al., Journal of neural transmission 1982 (Alcoholism...) : The growth hormone (GH) response to apomorphine HCl (Apo) ( 0.75 mg sc ), a dopamine ( DA ) receptor agonist, was assessed in healthy chronic alcoholics without cirrhosis ( N = 20 ) and in patients with alcoholic cirrhosis both with ( N = 5 ) and without ( N = 14 ) hepatic encephalopathy ( HE )
Mokrani et al., Psychoneuroendocrinology 1995 : Compared to a saline test, APO induced a significant increase of growth hormone (GH) , adrenocorticotropin ( ACTH ), and cortisol ( COR ) release and a decrease in prolactin (PRL) secretion
Brambilla et al., Biol Psychiatry 1997 : The dopaminergic function of 15 patients with OCD and 15 age/sex matched controls was evaluated by measuring the growth hormone (GH) responses to stimulation with the dopaminergic agonist apomorphine (APO) , which increases growth hormone releasing hormone (GHRH), GH, and somatomedine C (SMD-C) secretions